Activated T lymphocytes differentiate into effector cells tailored to meet
disparate challenges to host integrity(1). For example, type 1 and type 2 h
elper (T(H)1 and T(H)2) cells secrete cytokines that enhance cell-mediated
and humoral immunity, respectively. The chemokine monocyte chemoattractant
protein-1 (MCP-1) can stimulate interleukin-4 production(2) and its overexp
ression is associated with defects in cell-mediated immunity(3), indicating
that it might be involved in T(H)2 polarization. Here we show that MCP-1-d
eficient mice are unable to mount T(H)2 responses. Lymph node cells from im
munized MCP-1(-/-) mice synthesize extremely low levels of interleukin-4, i
nterleukin-5 and interleukin-10, but normal amounts of interferon-gamma and
interleukin-2. Consequently, these mice do not accomplish the immunoglobul
in subclass switch that is characteristic of T(H)2 responses and are resist
ant to Leishmania major. These effects are direct rather than due to abnorm
al cell migration, because the trafficking of naive T cells is undisturbed
in MCP-1(-/-) mice despite the presence of MCP-1-expressing cells in second
ary lymphoid organs of wild-type mice. Thus, MCP-1 influences both innate i
mmunity, through effects on monocytes, and adaptive immunity, through contr
ol of T helper cell polarization.